Differentiating Colonic Pathologies: A Brief Overview

Melanosis Coli: A Misnomer

Prolonged laxative use can lead to melanosis coli, characterized by brown or black pigmentation of the colonic mucosa. However, the pigment is not melanin but intact lipofuscin. Macrophages ingest apoptotic cells, and lysosomes convert the debris to lipofuscin pigment. The macrophages then become loaded with lipofuscin pigment, which is best identified under electron microscopy. Hence, some authors have proposed a new name – pseudomelanosis coli. Use of anthraquinone laxatives is most commonly associated with this syndrome.

Macrophages Containing Melanin

Melanosis coli is a misnomer. The pigment is not melanin. See the correct answer for a full explanation.

Non-Caseating Granuloma

Non-caseating granulomas are characteristic of Crohn’s disease microscopic pathology, as well as transmural inflammation. However, this patient is unlikely to have Crohn’s disease, because it normally presents with diarrhoea, abdominal pain, malaise/lethargy, and weight loss.

Non-Specific Colitis

Non-specific colitis is a general term which can be found in a variety of disorders. For example, laxative abuse can cause colonic inflammation. However, melanosis coli is a more specific answer.

Crypt Abscesses

Crypt abscesses are found in ulcerative colitis, as well as mucosal and submucosal inflammation. Normally, ulcerative colitis presents with bloody diarrhoea, abdominal pain, malaise/lethargy, and weight loss. This patient’s history of constipation and a single episode of bloody diarrhoea makes ulcerative colitis unlikely.

Understanding Colonic Pathologies

Diagnosis and Management of Gastrointestinal Neuroendocrine Tumour (NET)

A patient presenting with symptoms of diarrhoea, wheezing, and flushing may have a gastrointestinal neuroendocrine tumour (NET), also known as carcinoid syndrome. It is important to consider NET in the differential diagnosis, even in relatively young patients, as the average delay in diagnosis is 2-3 years.

Appropriate investigations include routine blood tests, gut hormone measurement, 24-hour urinary 5-hydroxyindoleacetic acid (5-HIAA) measurement, cross-sectional imaging, and gastrointestinal endoscopy. Management options include somatostatin analogues, peptide receptor radiotargeted therapy (PRRT), and molecularly targeted treatments such as sunitinib or everolimus.

Health/illness-related anxiety, or hypochondriasis, should be a diagnosis of exclusion, and physical causes should be addressed first. Irritable bowel syndrome may cause similar symptoms, but without hot flashes or asthma. Colorectal or gastric adenocarcinoma may also be considered, but the symptoms are more consistent with a NET.

Most gastrointestinal NETs are low grade, and even in metastatic disease, the median overall survival is around 10 years. Early diagnosis and appropriate management can improve outcomes for patients with NET.

The relationship between Raynaud’s phenomenon and dysphagia is important in identifying potential underlying systemic diseases such as scleroderma. Raynaud’s phenomenon is a common symptom found in scleroderma, a systemic disease that can cause dysphagia and oesophageal dysmotility. While Raynaud’s phenomenon may be the only early manifestation of scleroderma, gastrointestinal involvement can also occur in the early stages. Therefore, the combination of Raynaud’s phenomenon with oesophageal symptoms should prompt further investigation for scleroderma.

Arthritis is not a specific cause of dysphagia-related illness, although it may occur in a variety of diseases. In scleroderma, arthralgia is more common than arthritis. Globus pharyngeus, the sensation of having something stuck in the throat, can cause severe distress, but despite extensive investigation, there is no known cause. Malar rash, found in systemic lupus erythematosus (SLE), is not associated with dysphagia. Weakness is a non-specific symptom that may be a manifestation of psychiatric illness or malnutrition as a consequence of dysphagia, and cannot guide further management.

Understanding Budd-Chiari Syndrome: A Rare Disorder with Obstruction of Hepatic Venous Outflow

Budd-Chiari syndrome (BCS) is a rare disorder that involves obstruction or narrowing of the hepatic veins, which can lead to hepatic dysfunction, portal hypertension, and ascites. This condition is caused by venous thrombosis that forms anywhere from the hepatic venules up to the entrance of the inferior vena cava (IVC) at the right atrium. BCS typically presents with abdominal pain, ascites, and hepatomegaly, and obstruction of the IVC can cause prominence of venous collaterals in the back with upward direction flow and bipedal oedema.

Recognized risk factors for BCS include prothrombotic conditions, myeloproliferative conditions, hormonal treatment, pregnancy and puerperium, infections, malignancy, trauma, and autoimmune/rheumatological conditions such as sarcoidosis. Alcoholism, hyperthyroidism, hyperlipidaemia, and acute infection are not typically associated with BCS.

It is important to recognize the signs and symptoms of BCS and to identify any underlying risk factors in order to provide appropriate treatment and management.

When it comes to distinguishing between ulcerative colitis and Crohn’s disease, one key factor is the presence of crypt abscesses. These are typically seen in ulcerative colitis, which is the more common of the two inflammatory bowel diseases. In ulcerative colitis, inflammation starts in the rectum and spreads continuously up the colon, whereas Crohn’s disease often presents with skip lesions. Patients with ulcerative colitis may experience left-sided abdominal pain, cramping, bloody diarrhea with mucous, and unintentional weight loss. Colonoscopy typically reveals diffuse and contiguous ulceration and inflammatory infiltrates affecting the mucosa and submucosa only, with the presence of crypt abscesses being a hallmark feature. In contrast, Crohn’s disease is characterized by a transmural inflammatory phenotype, with non-caseating granulomas and stricturing of the bowel wall being common complications. Patients with Crohn’s disease may present with right-sided abdominal pain, watery diarrhea, and weight loss, and may have a more systemic inflammatory response than those with ulcerative colitis. Barium enema and colonoscopy can help to differentiate between the two conditions, with the presence of multiple linear ulcers in the bowel wall (rose-thorn appearance) and bowel wall thickening being suggestive of Crohn’s disease.

Diuretics for Ascites in Liver Cirrhosis: Mechanisms and Options

Ascites is a common complication of liver cirrhosis, caused by both Na/water retention and portal hypertension. Spironolactone, an aldosterone antagonist, is the first-line diuretic for ascites in liver cirrhosis. It promotes natriuresis and diuresis, while also preventing hypokalaemia and subsequent hepatic encephalopathy. Furosemide, a loop diuretic, can be used as an adjunct or second-line therapy. Bumetanide and amiloride are alternatives, but less preferred. Acetazolamide and thiazide diuretics are not recommended. Common side-effects of diuretics include electrolyte imbalances and renal impairment. Careful monitoring is necessary to ensure safe and effective treatment.

Understanding Achalasia: Symptoms, Diagnosis, and Differential Diagnosis

Achalasia is a motility disorder that affects the lower esophageal sphincter, causing difficulty swallowing both liquids and solids. This condition is characterized by the failure of the sphincter to relax in response to peristalsis during swallowing, which can lead to chest pain after eating and regurgitation of food. The cause of achalasia is unknown, but it is thought to be due to degeneration of the myenteric plexus.

To diagnose achalasia, a barium swallow may reveal a dilated esophagus with a bird’s beak tapering of the distal esophagus. Manometry can confirm the high-pressure, non-relaxing lower esophageal sphincter. Endoscopy should also be carried out to exclude malignancy.

Differential diagnosis for achalasia includes oesophageal carcinoma, pharyngeal pouch, benign oesophageal stricture, and caustic stricture. Oesophageal carcinoma is less likely in a relatively young patient without history of weight loss, and the barium swallow findings are more suggestive of achalasia than malignancy. A pharyngeal pouch would be visualized on a barium swallow, while a benign oesophageal stricture is more common in older people with a history of gastro-oesophageal reflux disease. Caustic stricture would also be visualized on a barium swallow, but there is no history of caustic damage in this case.

The patient had symptoms of biliary colic, including nausea, vomiting, and right upper quadrant pain, and an ultrasound scan revealed gallstones and a dilated common bile duct. While the patient’s pain has subsided, there is a risk of complications from gallstone disease. Magnetic resonance cholangiopancreatography is a non-invasive diagnostic procedure that visualizes the biliary and pancreatic ducts, but it does not offer a management option. Endoscopic retrograde cholangiopancreatography can diagnose and treat obstruction caused by gallstones, but it is only a symptomatic treatment and not a definitive management. Repeat ultrasound has no added value in management. The only definitive management for gallstones is cholecystectomy, or removal of the gallbladder. Doing nothing puts the patient at risk of complications.

Understanding the Signs and Symptoms of Peritonitis

Peritonitis is a condition characterized by inflammation of the peritoneum, the membrane lining the abdominal and pelvic cavity. It can be caused by various factors, including organ inflammation, viscus perforation, and bowel obstruction. Here are some of the common signs and symptoms of peritonitis:

Absent Bowel Sounds: This is the most indicative sign of generalised peritonitis, but it can also be present in paralytic ileus or complete bowel obstruction.

Guarding: This is the tensing of muscles of the abdominal wall, detected when palpating the abdomen, which protects an inflamed organ. It is present in localised and generalised peritonitis.

Pain Worse on Inspiration: Pain on inspiration can be a sign of either local or generalised peritonitis – the pain associated with peritonitis can be aggravated by any type of movement, including inspiration or coughing.

Rebound Tenderness: This is a clinical sign where pain is elicited upon removal of pressure from the abdomen, rather than on application of pressure. It is indicative of localised or generalised peritonitis.

Constant Abdominal Pain: This can have various causes, including bowel obstruction, necrotising enterocolitis, colonic infection, peritoneal dialysis, post-laparotomy or laparoscopy, and many more.

Understanding these signs and symptoms can help in the early detection and treatment of peritonitis. If you experience any of these symptoms, it is important to seek medical attention immediately.

Diagnosis and Management of Small Intestinal Bacterial Overgrowth (SIBO)

Small intestinal bacterial overgrowth (SIBO) is a condition that can cause malabsorption, steatorrhoea, and megaloblastic anaemia. It is often seen in patients who have had abdominal surgery and is characterized by an overgrowth of bacteria in the small intestine. The gold standard for diagnosis of SIBO is culture of small intestinal fluid aspirate, with a duodenal aspirate showing >105 CFU/ml considered a sensitive marker for SIBO.

SIBO is thought to develop as a failure of normal mechanisms that control bacterial growth within the small gut, with decreased gastric acid secretion and factors that affect gut motility being important. Any structural defect can have an effect on gut motility, and intestinal surgery predisposes patients to diverticular formation or stricture formation, both of which will lead to an increased risk of SIBO.

Bacterial overgrowth responds to antibiotic therapy, with many antibiotics being effective in SIBO, including metronidazole, ciprofloxacin, co-amoxiclav, and rifaximin. A 2-week course of antibiotics may be tried initially, but in many patients, long-term antibiotic therapy may be needed.

Other diagnostic tests for SIBO include hydrogen breath tests, which can give quick results but may be confounded by factors such as intestinal transit time, diet, smoking, and methane-producing bacteria. Serum folate levels and blood IgA-tTG levels are not diagnostic of SIBO, but intestinal biopsy specimens (unwashed) may be sent for culture.

In conclusion, SIBO is a common cause of malabsorption in the Western world, particularly in conditions where there is intestinal stasis or formation of a blind loop. Diagnosis is made through culture of small intestinal fluid aspirate, and treatment involves antibiotic therapy.

Autoantibodies and their association with autoimmune conditions

Autoimmune conditions are characterized by the body’s immune system attacking its own tissues and organs. Autoantibodies, or antibodies that target the body’s own cells, are often present in these conditions and can be used as diagnostic markers. Here are some examples of autoantibodies and their association with specific autoimmune conditions:

1. Anti-mitochondrial antibodies (type M2) are highly specific for primary biliary cholangitis, an autoimmune condition affecting the liver.

2. Anti-smooth muscle antibodies are associated with type 1 autoimmune hepatitis, a condition in which the immune system attacks the liver.

3. Anti-liver kidney microsomal antibodies are classically associated with type 2 autoimmune hepatitis, another condition affecting the liver.

4. Anti-double-stranded DNA antibodies are associated with systemic lupus erythematosus (SLE), a systemic autoimmune condition that can affect multiple organs.

5. p-ANCA antibodies occur in several autoimmune conditions, including microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, and primary sclerosing cholangitis.

Understanding Gilbert’s Syndrome and Its Differential Diagnosis

Gilbert’s syndrome is a genetic condition that affects the conjugation of bilirubin due to a defect in the bilirubin-uridine diphosphate (UDP) glucuronyl transferase enzyme. This results in an isolated rise in bilirubin levels during times of stress, fatigue, or viral illness. A 48-hour fast can confirm the diagnosis if it is unclear. The condition is benign and does not require specific treatment.

Crigler-Najjar syndrome is another condition that affects UDP glucuronyl transferase, but it presents with jaundice and typically results in death during the neonatal period.

Cholecystitis causes right upper quadrant abdominal pain and fever but does not typically result in jaundice. Acute ethanol poisoning can lead to alcoholic hepatitis, but the mild jaundice and overall well-being of the patient are more consistent with Gilbert’s syndrome.

Viral hepatitis can also cause jaundice, but the clinical picture is more in line with Gilbert’s syndrome. Understanding the differential diagnosis is crucial in determining the appropriate treatment and management for patients.

Ursodeoxycholic acid is a medication that can slow down the progression of liver failure in patients with primary biliary cholangitis (PBC). PBC is characterized by symptoms such as general itching, elevated levels of alkaline phosphatase and direct hyperbilirubinemia, and high levels of anti-mitochondrial antibodies. Ursodeoxycholic acid is a synthetic secondary bile acid that reduces the synthesis of cholesterol and bile acids in the liver, which helps to reduce the total bile acid pool and prevent hepatotoxicity caused by the accumulation of bile acids.

Corticosteroids are commonly used to treat autoimmune hepatitis.

Etanercept is a medication that inhibits tumour necrosis factor and is used to treat conditions such as rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis.

Lamivudine is a nucleoside analogue that can inhibit viral reverse transcriptase and is used to treat infections caused by HIV or HBV.

Cholestyramine is a medication that binds to bile acids in the intestinal lumen, preventing their reabsorption. It is used to treat conditions such as hypercholesterolemia, pruritus, and diarrhea.

Reliable Antibody Test for Coeliac Disease

Coeliac disease is an autoimmune condition that targets the gliadin epitope in gluten. It often presents in children with symptoms such as failure to thrive and diarrhoea, which can start during weaning. To diagnose coeliac disease, doctors use antibody tests such as anti-TTG, anti-endomysial antibody, and antigliadin. Among these, anti-TTG is the most reliable and is used as a first-line screening test due to its sensitivity of nearly 100%. Anti-endomysial antibodies are more expensive and observer-dependent, so they are not recommended as a first-line screening test. Antigliadin is rarely measured due to its lower accuracy. It is also important to measure IgA levels because IgA-deficient patients may be asymptomatic and cause a false-negative anti-TTG test.

Autoimmune Conditions and Antibody Tests

Autoimmune conditions can cause a variety of symptoms, including diarrhoea and bloating. Graves’ autoimmune thyroid disease, for example, may present with diarrhoea, but bloating is not commonly associated. To diagnose autoimmune conditions, doctors use antibody tests such as ANCA, which is raised in many autoimmune conditions, including some patients with ulcerative colitis. However, ANCA is not raised in coeliac disease. Therefore, it is important to use the appropriate antibody test for each autoimmune condition to ensure an accurate diagnosis.

Effects of Aspirin on Gastric Mucosal Lining

Aspirin is a commonly used medication for pain relief and anti-inflammatory purposes. However, it can have adverse effects on the gastric mucosal lining. One of the effects of aspirin is the reduction of surface mucous secretion, which normally protects the gastric mucosal lining. This is due to the inhibition of PGE2 production. To prevent gastrointestinal bleeding and peptic ulceration, patients taking aspirin should consider taking a proton pump inhibitor alongside it.

Aspirin has no effect on gastric motility, but it causes a reduction in PGI2, resulting in reduced blood flow to the gastric lining and mucosal ischaemia. This prevents the elimination of acid that has diffused into the submucosa. Aspirin also causes decreased surface bicarbonate secretion and increased acid production from gastric parietal cells, as prostaglandins normally inhibit acid secretion.

It is important to note that the risk factors for aspirin and non-steroidal anti-inflammatory drug (NSAID)-induced injury include advanced age, history of peptic ulcer disease, concomitant use of glucocorticoids, high dose of NSAIDs, multiple NSAIDs, and concomitant use of clopidogrel or anticoagulants. Therefore, patients should be cautious when taking aspirin and consult with their healthcare provider if they have any concerns.

The Adverse Effects of Aspirin on Gastric Mucosal Lining

Differential Diagnosis for Dysphagia: Achalasia, Acute Coronary Syndrome, Diffuse Oesophageal Spasm, Oesophageal Carcinoma, and Pill-Induced Oesophagitis

Dysphagia, or difficulty swallowing, can be caused by various conditions. Among the possible diagnoses, achalasia is the most suitable response for a patient who presents with dysphagia to both solids and liquids with regurgitation of food. Achalasia is a rare motility disorder that affects the oesophagus, resulting in the failure of the lower oesophageal sphincter to relax. The patient may also have a normal ECG and no atherosclerotic risk factors, ruling out acute coronary syndrome. Diffuse oesophageal spasm, which causes intermittent and poorly coordinated contractions of the distal oesophagus, is less likely as the patient has continuous symptoms. Oesophageal carcinoma, which typically presents with progressive dysphagia from solids to liquids, is also unlikely as the patient lacks risk factors for the disease. Pill-induced oesophagitis, on the other hand, should be suspected in patients with heartburn or dysphagia and a history of ingestion of medications known to cause oesophageal injury. In summary, the differential diagnosis for dysphagia includes achalasia, acute coronary syndrome, diffuse oesophageal spasm, oesophageal carcinoma, and pill-induced oesophagitis.

Liver Tumours: Types, Risk Factors, and Diagnostic Methods

Liver tumours are abnormal growths that develop in the liver. The most common primary liver tumour is hepatocellular carcinoma (HCC), which is often associated with hepatitis B infection, cirrhosis, male gender, and increasing age. Chronic hepatitis B is the major risk factor worldwide, while hepatitis C is the major risk factor in Europe. Patients with underlying cirrhosis may present with decompensation of liver disease, such as ascites, jaundice, worsening liver function tests, and variceal haemorrhage. Examination may reveal hepatomegaly or a right hypochondrial mass. Vascularity of the tumour may result in an audible bruit on auscultation.

Diagnostic methods for liver tumours include increased α-fetoprotein, which is produced by 60% of HCCs. Ultrasound scanning will reveal focal lesions and may also show involvement of the portal vein. Helical triple-phase computed tomography (CT) scanning will identify HCC due to its hypervascular nature. Alternatively, magnetic resonance imaging (MRI) may be used.

Other types of liver tumours include fibrosarcoma, which is an extremely rare primary tumour of the liver, cholangiocarcinoma, which are usually adenocarcinomas and are the second most common primary tumour of the hepatobiliary system, affecting biliary ducts, hepatoblastoma, which is a liver tumour that typically presents in childhood, in the first 3 years of life, and leiomyosarcoma, which is another rare primary tumour of the liver. Leiomyosarcoma is thought to affect women more than men and typically seems to present later in life, in the fifth and sixth decades of life. However, greater understanding of the epidemiology of these rare tumours is required.

Factors affecting liver injury following paracetamol overdose

Paracetamol overdose can lead to liver injury due to the formation of a reactive metabolite called N-acetyl-p-benzoquinone imine (NAPQI), which depletes the liver’s natural antioxidant glutathione and damages liver cells. Certain risk factors increase the likelihood of liver injury following paracetamol overdose. These include malnourishment, eating disorders (such as anorexia or bulimia), failure to thrive or cystic fibrosis in children, acquired immune deficiency syndrome (AIDS), cachexia, alcoholism, enzyme-inducing drugs, and regular alcohol consumption. The use of inhaled corticosteroids for asthma or selective serotonin reuptake inhibitors (SSRIs) does not increase the risk of hepatotoxicity. However, the antidote for paracetamol poisoning, acetylcysteine, acts as a precursor for glutathione and replenishes the body’s stores to prevent further liver damage. Overall, age does not significantly affect the risk of liver injury following paracetamol overdose.

Causes of Upper Gastrointestinal Bleeding and Their Differentiation

Upper gastrointestinal (GI) bleeding can have various causes, and it is important to differentiate between them to provide appropriate management. The following are some common causes of upper GI bleeding and their distinguishing features.

Bleeding Oesophageal Varices
Portal hypertension due to chronic liver failure can lead to oesophageal varices, which can rupture and cause severe bleeding, manifested as haematemesis. Immediate management includes resuscitation, proton pump inhibitors, and urgent endoscopy to diagnose and treat the source of bleeding.

Mallory-Weiss Tear
A Mallory-Weiss tear causes upper GI bleeding due to a linear mucosal tear at the oesophagogastric junction, secondary to a sudden increase in intra-abdominal pressure. It occurs in patients after severe retching and vomiting or coughing.

Peptic Ulcer
Peptic ulcer is the most common cause of serious upper GI bleeding, with the majority of ulcers in the duodenum. However, sudden-onset haematemesis of a large volume of fresh blood is more suggestive of a bleed from oesophageal varices. It is important to ask about a history of indigestion or peptic ulcers. Oesophagogastroduodenoscopy (OGD) can diagnose both oesophageal varices and peptic ulcers.

Gastric Ulcer
Sudden-onset haematemesis of a large volume of fresh blood is more suggestive of a bleed from oesophageal varices.

Oesophagitis
Oesophagitis may be very painful but is unlikely to lead to a significant amount of haematemesis.

Understanding the Causes of Upper Gastrointestinal Bleeding

Understanding Diverticulitis: Symptoms, Risk Factors, and Differential Diagnoses

Diverticulitis is a condition characterized by inflammation of diverticula, which are mucosal herniations through the muscle of the colon. While most people over 50 have diverticula, only 25% of them become symptomatic, experiencing left lower quadrant abdominal pain that worsens after eating and improves after bowel emptying. Low dietary fiber, obesity, and smoking are risk factors for diverticular disease, which can lead to complications such as perforation, obstruction, or abscess formation.

Bowel perforation is a potential complication of diverticulitis, but it is rare and usually accompanied by peritonitis. Pelvic inflammatory disease is a possible differential diagnosis in women, but it is unlikely in this case due to the lack of sexual partners for two years. Inflammatory bowel disease is more common in young adults, while diverticulosis is more prevalent in people over 50. Colorectal cancer is another differential diagnosis to consider, especially in older patients with a change in bowel habit and fever or tachycardia.

In summary, understanding the symptoms, risk factors, and differential diagnoses of diverticulitis is crucial for accurate diagnosis and appropriate management.